The test directly detects genetic sequences associated with TB and drug-resistant TB. Although researchers have known about these sequences since the mid-1990s, incorporating the molecular technologies needed to detect them into tests for the developing world has been impractical until recently, says David Persing, the chief medical and technology officer at Cepheid, the California-based company that manufactures the test.
The thought that counts
3 hours ago
No comments:
Post a Comment